Dow Corning Breast Implants
Dow Corning failed to perform enough tests to ensure the safety of silicone breast implants. Instead, based on a few trials, they rushed the product to the market in anticipation of great profits and ended instead having to file for bankruptcy. After receiving abundant evidence from thousands of suffering women, the FDA determined that these womens’ symptoms of poor health…and their discomforts ranging from extreme fatigue to pain in the muscles and joints and pain also from the implant itself, which caused a hardening around the tissue termed capsular contracture, were sufficient evidence that the Dow Corning people rushed the product to the market too soon.
Because the implants in some women split open, and their systems began attacking their own bodies as foreign objects, Dow was determined to be guilty of manufacturing a defective product in 1991. It countered that its product was safe and the issue was political zed. The FDA, however, did not buy that concept. Dow had based their safety decisions on a doctor’s testing upon dogs, which failed to be conclusive. Some Dow scientists even had misgivings over, silicone bleed, but they still released the implants to plastic surgeons. Subsequently, this company was pegged as having
Need essay sample on "Dow Corning Breast Implants"? We will write a custom essay sample specifically for you for only $ 13.90/page
They needed much more testing before they brought the product to the consumer.